Medicare Part D and Medicare Advantage plans with prescription drug coverage may cover Xarelto if it appears on the plan’s formulary. There are currently no generic alternatives available for Xarelto, ...
Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be manufactured at ...
Advisers to the Food and Drug Administration have voted against recommending approval of Johnson & Johnson’s blood-thinner Xarelto as a treatment for patients with acute coronary syndrome. Advisers to ...
NEW YORK, Feb 14 (Reuters) - U.S. health regulators have again declined to approve proposed wider uses of Bayer AG and Johnson & Johnson's lucrative blood clot preventer Xarelto, the drugmakers said ...
According to IQVIA MAT July 2025 data, Rivaroxaban for Oral Suspension, 1 mg/mL (RLD Xarelto) had estimated annual sales of USD 11 million in the US. Shares of Lupin Ltd ended at ₹1,920.95, down by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback